Basophil activation test in the diagnosis and monitoring of mastocytosis patients with wasp venom allergy on immunotherapy

Cytometry Part B - Clinical Cytometry

Volumn 86, Issue 3, 2014, Pages 183-190

  Bidad, Katayoon ^a,b   Nawijn, Martijn C ^b   Van Oosterhout, Antoon J M ^b   Van Der Heide, Sicco ^b   Oude Elberink, Joanne N G ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

basophil activation test; immunotherapy; mastocytosis; wasp venom allergy

Indexed keywords

ANTIGEN; CD203C ANTIGEN; CD63 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; TRYPTASE; UNCLASSIFIED DRUG; WASP VENOM; CD63 PROTEIN, HUMAN; ENPP3 PROTEIN, HUMAN; IMMUNOGLOBULIN G; INORGANIC PYROPHOSPHATASE; PHOSPHODIESTERASE;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BASOPHIL; BASOPHIL ACTIVATION TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL MONITORING; IMMUNOTHERAPY; INSECT ALLERGY; MAINTENANCE DRUG DOSE; MALE; MASTOCYTOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UPREGULATION; ANIMAL; BASOPHIL DEGRANULATION TEST; CHEMICALLY INDUCED; DESENSITIZATION; GENETICS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; TOXICITY;

ADULT; AGED; ANIMALS; ANTIGENS, CD63; BASOPHIL DEGRANULATION TEST; BASOPHILS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GENE EXPRESSION; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MASTOCYTOSIS; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; TRYPTASES; WASP VENOMS;

EID: 84898546727     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21148     Document Type: Article

References (43)

1. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, Leung DY, Lotvall J, Marone G, Metcalfe DD, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007; 120 (1 Suppl): S2-24.
2. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, et al. Second symposium on the definition and management of anaphylaxis: Summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397.
3. Scherer K, Bircher AJ, Heijnen IA,. Diagnosis of stinging insect allergy: Utility of cellular in-vitro tests. Curr Opin Allergy Clin Immunol 2009; 9: 343-350.
4. Valent P, Horny HP, Triggiani M, Arock M,. Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria. Int Arch Allergy Immunol 2011; 156: 119-127.
5. Ozdemir D, Dagdelen S, Erbas T,. Systemic mastocytosis. Am J Med Sci 2011; 342: 409-415.
6. van Anrooij B, van der Veer E, de Monchy JG, van der Heide S, Kluin-Nelemans JC, van Voorst Vader PC, van Doormaal JJ, Oude Elberink JN,. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis. J Allergy Clin Immunol 2013; 132: 125-130.
7. Bonadonna P, Zanotti R, Muller U,. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol 2010; 10: 347-353.
8. Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA,. Mechanisms of immunotherapy to wasp and bee venom. Clin Exp Allergy 2011; 41: 1226-1234.
9. Golden DB, Kelly D, Hamilton RG, Craig TJ,. Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol 2009; 123: 1371-1375.
10. Sainte-Laudy J, Sabbah A, Drouet M, Lauret MG, Loiry M,. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 2000; 30: 1166-1171.
11. Kucera P, Cvackova M, Hulikova K, Juzova O, Pachl J,. Basophil activation can predict clinical sensitivity in patients after venom immunotherapy. J Investig Allergol Clin Immunol 2010; 20: 110-116.
12. Hamilton RG,. Diagnostic methods for insect sting allergy. Curr Opin Allergy Clin Immunol 2004; 4: 297-306.
13. Dubois AE, van der Heide S,. Basophil-activation tests in Hymenoptera allergy. Curr Opin Allergy Clin Immunol 2007; 7: 346-349.
14. Nopp A, Johansson SG, Ankerst J, Bylin G, Cardell LO, Gronneberg R, Irander K, Palmqvist M, Oman H,. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006; 61: 298-302.
15. Nopp A, Cardell LO, Johansson SG, Oman H,. CD-sens: A biological measure of immunological changes stimulated by ASIT. Allergy 2009; 64: 811-814.
16. Sainte-Laudy J, Touraine F,. Use of basophil sensitivity not reactivity as a good marker for allergy diagnosis. Inflamm Res 2009; 58 (Suppl 1): 28-29.
17. Lalek N, Kosnik M, Silar M, Korosec P,. Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy. Clin Exp Allergy 2010; 40: 1186-1193.
18. Eberlein B,. Basophil activation test in the diagnosis of insect venom allergies. Clin Exp Allergy 2009; 39: 1633-1634.
19. Mikkelsen S, Bibby BM, Dolberg MK, Dahl R, Hoffmann HJ,. Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy. Clin Mol Allergy 2010; 8: 2.
20. Ebo DG, Bridts CH, Hagendorens MM, Aerts NE, De Clerck LS, Stevens WJ,. Basophil activation test by flow cytometry: Present and future applications in allergology. Cytometry Part B Clin Cytom 2008; 74B: 201-210.
21. Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B,. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet. 2001; 357: 361-362.
22. Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA,. Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435-453.
23. Mueller HL,. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966; 3: 331-333.
24. Peternelj A, Silar M, Erzen R, Kosnik M, Korosec P,. Basophil sensitivity in patients not responding to venom immunotherapy. Int Arch Allergy Immunol 2008; 146: 248-254.
25. Ebo DG, Hagendorens MM, Schuerwegh AJ, Beirens LM, Bridts CH, De Clerck LS, Stevens WJ,. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy. Cytometry Part B Clin Cytom 2007; 72B: 196-203.
26. Lambert C, Guilloux L, Dzviga C, Gourgaud-Massias C, Genin C,. Flow cytometry versus histamine release analysis of in vitro basophil degranulation in allergy to Hymenoptera venom. Cytometry Part B Clin Cytom 2003; 52B: 13-19.
27. Boumiza R, Debard AL, Monneret G,. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005; 3: 9.
28. Erdmann SM, Sachs B, Kwiecien R, Moll-Slodowy S, Sauer I, Merk HF,. The basophil activation test in wasp venom allergy: Sensitivity, specificity and monitoring specific immunotherapy. Allergy 2004; 59: 1102-1109.
29. Bilo MB,. Anaphylaxis caused by Hymenoptera stings: From epidemiology to treatment. Allergy 2011; 66 (Suppl 95): 35-37.
30. Korosec P, Erzen R, Silar M, Bajrovic N, Kopac P, Kosnik M,. Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results. Clin Exp Allergy 2009; 39: 1730-1737.
31. Ebo DG, Hagendorens MM, Bridts CH, De Clerck LS, Stevens WJ,. Hymenoptera venom allergy: taking the sting out of difficult cases. J Investig Allergol Clin Immunol 2007; 17: 357-360.
32. Bonadonna P, Zanotti R, Melioli G, Antonini F, Romano I, Lenzi L, Caruso B, Passalacqua G,. The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting. Allergy 2012; 67: 962-965.
33. Golden DB,. Long-term outcome after venom immunotherapy. Curr Opin Allergy Clin Immunol 2010; 10: 337-341.
34. Ebo DG, Hagendorens MM, Stevens WJ,. Hymenoptera venom allergy. Expert Rev Clin Immunol 2005; 1: 169-175.
35. Plewako H, Wosinska K, Arvidsson M, Bjorkander J, Skov PS, Hakansson L, Rak S,. Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy. Int Arch Allergy Immunol 2006; 141: 346-353.
36. Siegmund R, Vogelsang H, Machnik A, Herrmann D,. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy. J Allergy Clin Immunol 2000; 106: 1190-1195.
37. Nullens S, Sabato V, Faber M, Leysen J, Bridts CH, De Clerck LS, Falcone FH, Maurer M, Ebo DG,. Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry. Cytometry Part B Clin Cytom 2013; 84B: 173-178.
38. Nagao M, Hiraguchi Y, Hosoki K, Tokuda R, Usui T, Masuda S, Yamaguchi M, Fujisawa T,. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol 2008; 146 (Suppl 1): 47-53.
39. De Week AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, Demoly P, Ebo DG, Mayorga L, Monneret G, et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues. J Investig Allergol Clin Immunol 2008; 18: 143-155.
40. Gonzalez-de-Olano D, Alvarez-Twose I, Morgado JM, Esteban Lopez MI, Vega Castro A, Diaz de Durana MD, Sanchez-Munoz L, Matito A, de la Hoz Caballer B, Sanz ML, et al. Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis. Cytometry Part B Clin Cytom 2011; 80B: 167-175.
41. Przybilla B, Rueff F,. Hymenoptera venom allergy. J Dtsch Dermatol Ges 2010; 8: 114-127; quiz 28-30.
42. Verweij MM, De Knop KJ, Bridts CH, De Clerck LS, Stevens WJ, Ebo DG,. P38 mitogen-activated protein kinase signal transduction in the diagnosis and follow up of immunotherapy of wasp venom allergy. Cytometry Part B Clin Cytom 2010; 78B: 302-307.
43. Verweij MM, Sabato V, Nullens S, Bridts CH, De Clerck LS, Stevens WJ, Ebo DG,. STAT5 in human basophils: IL-3 is required for its FcepsilonRI-mediated phosphorylation. Cytometry Part B Clin Cytom 2012; 82B: 101-106.